Ann: Positive interim TACTI-mel data presented at SITC, page-29

No relevance to IMM but I thought I might pass it on because it's something
I haven't considered before......In relation to trial set-ups....
Watched CNBC fox 644 early this morning when this was reported........
A company called Amiren released results for a heart treatment based on
a fish oil base, it was ph2 and were good......however in the placebo part of
the trial patients were treated with some form of mineral oil....the placebo part
of the trial weren't good at all....anyway the shares tanked because analysts thought
the placebo section of the trial was designed for poor results to make the
fish oil treatment look better......